Medical-Grade Expanded Polyethylene (EPE) Market latest Statistics on Market Size, Growth, Production, Sales Volume, Sales Price, Market Share and Import vs Export 

Medical-Grade Expanded Polyethylene (EPE) Market Summary Highlights

The Medical-Grade Expanded Polyethylene (EPE) Market is estimated at approximately USD 1.48 billion in 2026, supported by rising use of lightweight sterile packaging, diagnostic equipment cushioning, orthopedic protection products, and temperature-sensitive pharmaceutical logistics. Demand patterns are increasingly linked to healthcare infrastructure investments, biologics transportation, and the expansion of single-use medical devices across North America and Asia-Pacific. Medical foam converters and polymer suppliers are also adjusting production lines toward recyclable and low-VOC grades as healthcare procurement standards tighten in Europe and parts of East Asia.

In 2026, procurement activity from medical packaging manufacturers remains one of the strongest contributors to consumption growth. Expanded polyethylene foam is being specified for surgical instrument trays, implant protection inserts, prosthetic cushioning, and reusable cold-chain containers because of its shock absorption, moisture resistance, and chemical stability. At the same time, pressure on hospital systems to reduce packaging waste is influencing resin selection and multilayer foam design strategies.

Recent developments across the healthcare materials ecosystem continue to influence the Medical-Grade Expanded Polyethylene (EPE) Market. In February 2026, the European Commission advanced implementation discussions around revised packaging sustainability requirements affecting medical transport materials and polymer recyclability targets. In November 2025, Sealed Air expanded healthcare packaging operations in North America with additional automation capabilities for temperature-controlled medical shipping solutions. In January 2026, Japan’s Ministry of Health supported funding for advanced pharmaceutical cold-chain logistics infrastructure, indirectly strengthening demand for high-performance protective foam materials used in biologics transport.

Statistical Highlights

• The Medical-Grade Expanded Polyethylene (EPE) Market is projected to reach USD 1.48 billion in 2026, with forecast CAGR of 6.7% through 2031.
• Medical protective packaging applications account for nearly 41% of global EPE foam demand in healthcare sectors during 2026.
• Pharmaceutical cold-chain transport usage is expected to rise by 8.9% in 2026 due to biologics and vaccine distribution growth.
• Asia-Pacific represents approximately 38% of global consumption volume, led by China, Japan, South Korea, and India.
• Sterile device packaging conversion demand increased by an estimated 7.4% year-over-year in 2026.
• Cross-linked medical-grade polyethylene foam products contribute nearly 46% of total market revenue because of higher durability and cleanliness standards.
• North America maintains more than 31% revenue share owing to strong medical device manufacturing and advanced healthcare logistics infrastructure.
• Recyclable or partially recycled-content medical EPE solutions are expected to account for 18% of newly launched healthcare foam products in 2026.
• Hospital equipment cushioning and patient positioning products together contribute nearly 22% of end-use demand.
• Pharmaceutical exports requiring insulated transit protection are forecast to exceed USD 980 billion globally in 2026, supporting long-distance medical foam packaging requirements.
• Medical device manufacturing output in Southeast Asia is projected to expand by over 9% in 2026, increasing regional demand for precision protective foam materials.

Healthcare Cold-Chain Expansion Supporting Foam Consumption

Temperature-controlled pharmaceutical logistics has become one of the most influential demand generators for medical-grade polyethylene foam products. Biologics, cell therapies, specialty injectables, and diagnostic reagents require stable transport conditions with strong vibration protection and thermal insulation. This has increased the adoption of expanded polyethylene cushioning inserts and insulated transport assemblies across pharmaceutical supply chains.

The International Air Transport Association estimated continued double-digit growth in global pharmaceutical air cargo handling volumes entering 2026, particularly for high-value biologics. Such movement directly increases requirements for impact-resistant medical foam packaging capable of preserving product integrity during long-distance shipping.

Medical foam converters are increasingly producing customized EPE structures with anti-static, antimicrobial, and low-particulate properties for healthcare logistics. These materials are widely integrated into vaccine transit boxes, insulated medication shippers, and reusable transport systems. In Germany and the Netherlands, several pharmaceutical logistics operators expanded reusable thermal packaging pools during late 2025 to reduce operational waste and maintain compliance with pharmaceutical transport regulations.

Demand momentum is also visible in Asia. India’s pharmaceutical exports are forecast to cross USD 35 billion in 2026, while injectable drug exports continue to rise across regulated markets. This is strengthening demand for protective foam inserts used in sterile packaging and insulated transit systems.

Rising Single-Use Medical Device Production

The Medical-Grade Expanded Polyethylene (EPE) Market is closely connected with the increasing production of disposable medical devices. Catheters, surgical kits, IV systems, diagnostic cartridges, and minimally invasive surgical tools require reliable transit protection and sterile packaging compatibility. Expanded polyethylene foam provides low abrasion, chemical resistance, and dimensional stability, making it suitable for such applications.

The United States remains one of the largest medical device manufacturing hubs globally. The U.S. Food and Drug Administration continued device approval acceleration programs through 2025 for selected diagnostic and monitoring systems, supporting production expansion among OEM suppliers. Increased device manufacturing translates directly into higher consumption of precision protective packaging materials.

China is also strengthening its domestic medical device ecosystem. During 2025, multiple provinces announced incentives for high-end medical equipment manufacturing clusters, including Suzhou and Shenzhen. These industrial developments are expanding local requirements for protective healthcare packaging materials, including medical-grade EPE foams.

Another important factor is the rapid growth of home healthcare products. Portable oxygen systems, wearable monitors, insulin delivery devices, and home diagnostic kits increasingly require lightweight protective packaging optimized for e-commerce distribution. This trend has increased demand for customized foam inserts with precise dimensional performance.

Sustainability Pressures Changing Material Specifications

Environmental compliance requirements are influencing purchasing decisions across healthcare packaging operations. Although medical applications maintain strict hygiene standards that limit unrestricted recycled material use, healthcare companies are increasingly demanding recyclable mono-material protective packaging solutions.

This shift is affecting the Medical-Grade Expanded Polyethylene (EPE) Market in multiple ways. Manufacturers are investing in lower-density foam formulations, recyclable transport packaging systems, and improved material recovery processes. Several packaging producers introduced reusable healthcare shipping containers between 2025 and 2026 to reduce packaging disposal costs.

In March 2026, healthcare packaging suppliers in Europe accelerated qualification programs for recyclable foam transport assemblies following implementation updates linked to the EU Packaging and Packaging Waste Regulation framework. Procurement teams are increasingly evaluating lifecycle performance rather than focusing only on initial packaging cost.

Japanese manufacturers have also intensified development of lightweight polyethylene foam structures with reduced material consumption while maintaining cushioning efficiency. These product redesigns are particularly relevant in high-frequency pharmaceutical shipping routes where packaging volume reduction lowers transportation expenses.

Expansion of Diagnostic and Laboratory Infrastructure

Growth in clinical diagnostics, molecular testing, and laboratory automation is supporting additional demand for medical protective foam materials. Diagnostic instruments and precision laboratory equipment require shock-resistant transit packaging to prevent calibration damage and contamination risks.

Healthcare infrastructure spending across Southeast Asia and the Middle East remains particularly important for this segment. Saudi Arabia continued healthcare modernization investments during 2025 and 2026 under its national transformation initiatives, increasing imports of laboratory systems and specialized medical devices. Such expansion indirectly benefits suppliers of advanced protective packaging materials.

Expanded polyethylene foam is increasingly used for:

• Laboratory instrument cushioning
• Diagnostic kit transit inserts
• Imaging equipment protection
• Portable medical electronics packaging
• Reusable sterile transport cases

The increasing shipment of compact diagnostic devices for decentralized healthcare is creating additional opportunities for engineered foam converters. Portable ultrasound systems, handheld analyzers, and telehealth monitoring devices require lightweight but durable transport protection suitable for repeated handling cycles.

Shift Toward Higher-Purity and Cross-Linked Foam Grades

Performance expectations in healthcare packaging continue to rise. Buyers are demanding cleaner materials with low odor, minimal particulate shedding, improved dimensional consistency, and stronger resistance to sterilization environments. This is encouraging the transition from standard polyethylene foam toward advanced cross-linked variants.

Cross-linked expanded polyethylene grades are gaining preference in orthopedic support products, reusable surgical trays, and precision instrument packaging because of their enhanced surface finish and structural integrity. These materials also perform better in applications involving repeated cleaning cycles and extended storage periods.

Manufacturers in South Korea and Japan increased investment in specialty medical polymer processing capacity during 2025, partly to support premium healthcare packaging demand. In parallel, automation within foam fabrication operations is improving precision cutting capabilities for complex medical device packaging geometries.

The Medical-Grade Expanded Polyethylene (EPE) Market is therefore evolving beyond basic cushioning applications. Product differentiation is increasingly linked to cleanliness certification, thermal performance, design customization, and recyclability compatibility rather than simply foam thickness or density.

Healthcare Infrastructure Investments Sustaining Long-Term Demand

Hospital expansion projects and healthcare capital expenditure continue to support baseline consumption across the medical foam ecosystem. Emerging economies are increasing procurement of imaging systems, surgical instruments, robotic equipment, and emergency response devices, all of which require protective packaging and transport cushioning.

India allocated higher healthcare infrastructure expenditure in the 2026 fiscal framework, while several ASEAN economies continued expanding hospital construction programs. These developments support regional growth in medical equipment imports and domestic manufacturing activity.

In North America, aging population trends continue increasing demand for orthopedic products, rehabilitation devices, and mobility equipment that utilize medical polyethylene foam components for comfort and impact absorption. This is helping diversify end-use demand beyond packaging alone.

As healthcare supply chains become more globalized and sensitive to product integrity requirements, the role of engineered protective materials continues to expand. The Medical-Grade Expanded Polyethylene (EPE) Market is therefore expected to maintain stable medium-term demand growth, particularly in applications requiring lightweight protection, thermal stability, and compliance with increasingly strict healthcare logistics standards.

Geographical Demand Patterns in the Medical-Grade Expanded Polyethylene (EPE) Market

Regional consumption trends in the Medical-Grade Expanded Polyethylene (EPE) Market remain strongly aligned with healthcare manufacturing concentration, pharmaceutical exports, and medical device logistics activity. North America and Asia-Pacific together account for more than two-thirds of global demand in 2026, while Europe continues to emphasize higher-purity and recyclable medical foam specifications.

North America Maintaining High-Value Consumption

The United States continues to represent the largest single-country consumer in the Medical-Grade Expanded Polyethylene (EPE) Market due to the scale of its pharmaceutical packaging and medical device manufacturing sectors. The country accounts for nearly 28% of global medical-grade polyethylene foam demand in 2026.

The U.S. Census Bureau reported continued expansion in healthcare manufacturing investments through late 2025, particularly in medical diagnostics, injectable drug production, and surgical technologies. Such developments support increasing usage of EPE cushioning systems for sterile packaging and protective transport.

Demand growth is particularly visible in:

• Biologics cold-chain packaging
• Surgical instrument protection
• Diagnostic device cushioning
• Portable monitoring equipment packaging
• Orthopedic and rehabilitation supports

Mexico is also emerging as a regional production-support hub. Several multinational medical device manufacturers expanded operations in Baja California and Nuevo León during 2025 to strengthen North American supply chain resilience. This trend is increasing procurement of medical protective foams for export-oriented packaging applications.

Canada continues to see stable demand from pharmaceutical transit packaging and laboratory equipment imports. Government-supported healthcare modernization programs are sustaining procurement of advanced medical systems requiring engineered foam protection.

Asia-Pacific Driving Volume Expansion

Asia-Pacific holds the largest volume share in the Medical-Grade Expanded Polyethylene (EPE) Market, supported by large-scale healthcare manufacturing growth in China, Japan, India, and South Korea. The region contributes approximately 38% of global demand volume in 2026.

China remains central to global medical equipment exports. The National Medical Products Administration continued fast-track support for domestic high-end medical manufacturing during 2025 and 2026, encouraging expansion in imaging systems, diagnostic devices, and surgical instruments. This is directly supporting consumption of customized polyethylene foam packaging.

Japan’s demand structure differs from China’s volume-focused model. Japanese healthcare packaging companies prioritize premium low-particulate and cross-linked foam grades designed for reusable medical transport systems and high-precision equipment protection. Aging demographics and rising demand for rehabilitation devices are also contributing to steady domestic consumption.

India is recording one of the fastest growth rates in the Medical-Grade Expanded Polyethylene (EPE) Market. Pharmaceutical exports, vaccine production, and hospital infrastructure expansion are increasing demand for insulated transport packaging and sterile cushioning materials. India’s medical devices sector is projected to exceed USD 20 billion in manufacturing value by 2026, creating stronger downstream demand for medical-grade foam solutions.

South Korea continues to strengthen its position in biologics manufacturing and laboratory automation. Investments in pharmaceutical exports and biosimilar production are generating higher requirements for thermal-protective healthcare packaging materials.

Europe Prioritizing Sustainability and Reusable Packaging

European demand growth is comparatively moderate in volume terms but stronger in value-added applications. Germany, France, the Netherlands, and Switzerland remain major consumers of high-specification medical polyethylene foam materials.

The European healthcare packaging sector is increasingly influenced by sustainability regulations and procurement standards. In 2026, healthcare distributors and pharmaceutical exporters are placing greater emphasis on reusable insulated transport systems, recyclable packaging assemblies, and material traceability.

Germany remains Europe’s largest medical technology manufacturing base. The country’s advanced diagnostics and surgical equipment exports continue to support demand for engineered protective foam inserts with precision-cut designs.

The Netherlands is strengthening its role in pharmaceutical logistics. Expansion in cold-chain warehousing capacity around Rotterdam and Schiphol during late 2025 increased demand for reusable thermal transport systems using expanded polyethylene insulation layers.

Eastern Europe is also witnessing gradual growth as medical manufacturing shifts toward lower-cost production environments. Poland and the Czech Republic are attracting additional contract manufacturing investments linked to European healthcare supply chains.

Medical-Grade Expanded Polyethylene (EPE) Market Segmentation Highlights

By Product Type

• Cross-linked EPE foam accounts for nearly 46% of total revenue in 2026 due to higher purity and structural consistency.
• Non-cross-linked grades continue to dominate low-cost disposable packaging applications.
• Anti-static medical EPE variants are witnessing demand growth above 8% annually because of sensitive diagnostic equipment transport requirements.
• Recyclable mono-material polyethylene foam products are gaining procurement preference in Europe and Japan.

By Application

• Medical protective packaging contributes approximately 41% of total market demand.
• Pharmaceutical cold-chain logistics represents nearly 24% share in 2026.
• Orthopedic support and cushioning products contribute around 14%.
• Diagnostic equipment packaging demand is expanding at more than 7% annually.
• Hospital equipment protection and reusable transport containers continue to gain share across institutional procurement systems.

By End User

• Medical device manufacturers remain the largest end-user category.
• Pharmaceutical logistics providers are among the fastest-growing buyers of advanced polyethylene foam systems.
• Hospitals and diagnostic laboratories continue increasing procurement of reusable transport packaging.
• Contract packaging companies are expanding customized foam fabrication capacity to support sterile healthcare supply chains.

Medical-Grade Expanded Polyethylene (EPE) Production Trends

Global Medical-Grade Expanded Polyethylene (EPE) production is estimated to exceed 415 kilotons in 2026, supported by healthcare packaging demand and expansion in pharmaceutical logistics infrastructure. Asia-Pacific contributes more than half of total Medical-Grade Expanded Polyethylene (EPE) production capacity, led by China, Japan, and South Korea.

China continues to expand Medical-Grade Expanded Polyethylene (EPE) production through integrated polymer processing facilities located near medical manufacturing clusters in Guangdong, Jiangsu, and Zhejiang provinces. Japanese producers remain focused on specialty medical-grade and cross-linked foam manufacturing with tighter purity standards and higher export value. North American manufacturers are increasing automation investments to improve precision foam fabrication for diagnostic and surgical packaging applications. Production lines across Europe are increasingly being optimized for recyclable healthcare packaging solutions and lower material wastage.

Several foam converters also expanded CNC cutting and thermoforming operations during 2025 and 2026 to meet growing customization requirements from medical device OEMs. This trend is shifting production economics toward higher-margin engineered foam assemblies rather than commodity foam sheet supply.

Medical-Grade Expanded Polyethylene (EPE) Price Analysis

Raw material volatility remains a major factor influencing Medical-Grade Expanded Polyethylene (EPE) Price movements in 2026. Ethylene feedstock pricing, polymer resin supply conditions, energy costs, and transportation expenses continue affecting converter margins globally.

Average Medical-Grade Expanded Polyethylene (EPE) Price levels in 2026 are estimated between USD 3,200 and USD 5,100 per metric ton depending on density, purity, cross-linking technology, and customization requirements. High-purity cross-linked medical grades command substantially higher pricing due to additional processing requirements and regulatory compliance costs.

North America currently maintains the highest average Medical-Grade Expanded Polyethylene (EPE) Price levels because of elevated labor and compliance expenses. In contrast, China and Southeast Asia continue offering comparatively lower conversion costs, although export-oriented medical grades have seen price increases due to stronger quality certification requirements.

Medical-Grade Expanded Polyethylene (EPE) Price Trend

The Medical-Grade Expanded Polyethylene (EPE) Price Trend during 2025–2026 has reflected moderate upward movement after earlier petrochemical cost stabilization. Energy pricing fluctuations in Europe and freight normalization across Asia-Pacific influenced procurement contracts during the first half of 2026.

The Medical-Grade Expanded Polyethylene (EPE) Price Trend is also being shaped by demand for recyclable and reusable healthcare packaging systems. Manufacturers investing in cleaner production technologies and advanced foam fabrication processes are gradually transferring part of these costs into premium product pricing structures.

Cross-linked variants recorded stronger price appreciation than standard non-cross-linked products because of increasing healthcare demand for reusable packaging durability and improved cleanliness standards. Medical-grade anti-static foam products also experienced tighter supply conditions during early 2026 due to rising semiconductor-linked diagnostic equipment shipments.

Procurement strategies are increasingly shifting toward long-term supply agreements rather than spot purchasing, especially among pharmaceutical logistics providers managing temperature-sensitive biologics distribution. This approach is helping reduce short-term pricing volatility within the Medical-Grade Expanded Polyethylene (EPE) Market while supporting stable production planning for foam converters and polymer suppliers.

Leading Manufacturers in the Medical-Grade Expanded Polyethylene (EPE) Market

The Medical-Grade Expanded Polyethylene (EPE) Market is characterized by the presence of global protective packaging companies, specialty foam manufacturers, and regional healthcare material converters focused on medical packaging, pharmaceutical logistics, and diagnostic equipment protection. Competition has shifted steadily toward engineered healthcare applications requiring higher purity standards, customized fabrication, thermal insulation performance, and recyclable material compatibility.

Manufacturers are increasingly investing in cleanroom-compatible foam processing, precision cutting technologies, and reusable cold-chain packaging systems to strengthen their position in healthcare supply chains. Product differentiation is no longer limited to foam density or cushioning performance. Buyers are prioritizing low particulate generation, anti-static properties, sterilization resistance, and dimensional stability for sensitive medical applications.

Sealed Air Corporation

Sealed Air remains one of the largest participants in the Medical-Grade Expanded Polyethylene (EPE) Market due to its strong healthcare packaging and temperature-controlled logistics portfolio. The company supplies engineered protective foam systems used in pharmaceutical transport, surgical device packaging, and biologics distribution.

Its healthcare packaging operations are supported by advanced automation and integrated packaging design capabilities. Product offerings include insulated protective systems, fabricated foam inserts, and cushioning materials designed for sterile medical equipment transit.

The company holds a particularly strong position in North America and Europe where pharmaceutical exports and medical device manufacturing volumes remain high. Sealed Air is estimated to account for around 11% to 13% of the global market revenue in 2026.

JSP Corporation

JSP Corporation continues expanding its role in engineered polyolefin foams for healthcare applications. The company’s advanced foam technologies are widely used in reusable medical transport systems, diagnostic equipment packaging, and lightweight sterile cushioning solutions.

Its ARPLANK polyolefin foam products are increasingly preferred for applications requiring dimensional precision and low contamination characteristics. JSP maintains production and conversion facilities across Japan, China, and Europe, enabling strong supply chain integration for healthcare packaging customers.

The company is estimated to hold approximately 8% to 10% share of the Medical-Grade Expanded Polyethylene (EPE) Market in 2026.

Zotefoams plc

Zotefoams has established a strong position in premium medical foam applications through its cross-linked polyolefin foam technologies. The company’s Plastazote and Evazote product lines are widely used in orthopedic supports, prosthetic cushioning, rehabilitation products, and medical protective packaging.

Its materials are recognized for low-density performance, purity consistency, and durability under repeated handling conditions. Demand for these specialty foams has increased as healthcare providers seek reusable and longer-life cushioning solutions for medical devices and transport systems.

Zotefoams maintains a strong presence in Europe and high-specification healthcare applications across North America.

Pregis

Pregis has expanded healthcare-focused protective packaging capabilities through customized foam fabrication and recyclable packaging initiatives. The company supplies polyethylene foam rolls, fabricated inserts, and engineered protective assemblies for medical devices and pharmaceutical logistics.

Its healthcare customers increasingly require lightweight packaging systems capable of reducing transportation costs while maintaining shock absorption performance. Pregis has responded by investing in automation and sustainable packaging technologies targeted at healthcare procurement standards.

The company continues strengthening relationships with medical OEM manufacturers requiring precision foam conversion for sterile packaging applications.

UFP Technologies

UFP Technologies operates as a specialized supplier of engineered packaging and custom foam solutions for healthcare industries. Its portfolio includes sterile packaging components, protective medical cushioning systems, and advanced fabricated foam assemblies for diagnostic and surgical equipment.

The company has increased investment in cleanroom manufacturing and precision fabrication systems as healthcare clients demand stricter contamination control standards. UFP Technologies benefits from long-term relationships with medical device manufacturers and pharmaceutical packaging suppliers.

Its market share remains smaller than multinational packaging leaders but continues to expand in high-value engineered healthcare applications.

Medical-Grade Expanded Polyethylene (EPE) Market Share by Manufacturers

The top five manufacturers collectively account for nearly 42% to 48% of total global revenue in the Medical-Grade Expanded Polyethylene (EPE) Market during 2026. However, the industry still remains fragmented because of the large number of regional converters supplying customized healthcare packaging solutions.

Large multinational suppliers dominate premium medical applications involving:

• Biologics transport packaging
• Reusable cold-chain systems
• High-purity diagnostic equipment cushioning
• Precision surgical instrument protection
• Cross-linked medical foam assemblies

Regional manufacturers continue competing aggressively in standard medical cushioning and lower-cost healthcare packaging applications, particularly across Asia-Pacific.

Chinese converters are gaining export competitiveness because of lower production costs and expanding domestic medical device manufacturing. Several local producers are increasing investments in anti-static medical foam products and precision fabrication technologies to compete in higher-value healthcare applications.

Japanese manufacturers remain focused on technologically advanced medical-grade polyethylene foams with higher cleanliness standards and improved thermal insulation performance. European suppliers are emphasizing recyclable foam structures and reusable healthcare transport packaging to align with tightening sustainability regulations.

North American producers continue benefiting from strong pharmaceutical logistics activity and rising demand for specialty diagnostic equipment packaging. The region also maintains high demand for custom-fabricated protective foam inserts used in minimally invasive surgical systems and portable healthcare electronics.

Competitive Trends in the Medical-Grade Expanded Polyethylene (EPE) Market

Competition across the Medical-Grade Expanded Polyethylene (EPE) Market is increasingly influenced by healthcare supply chain requirements rather than commodity polymer pricing alone.

Manufacturers are prioritizing:

• Cross-linked medical foam development
• Recyclable polyethylene foam systems
• Lightweight thermal insulation structures
• Anti-static healthcare packaging materials
• CNC precision-cut fabrication
• Cleanroom-compatible processing technologies

The expansion of biologics distribution and temperature-sensitive pharmaceutical transport is encouraging packaging suppliers to develop reusable insulated systems with longer operational life cycles. Companies capable of integrating thermal protection with lightweight impact cushioning are gaining stronger positioning among pharmaceutical logistics providers.

At the same time, growth in home healthcare equipment and portable diagnostic systems is increasing demand for compact engineered foam packaging with higher durability and dimensional accuracy.

Recent Industry Developments

• April 2026 – Sealed Air completed a major acquisition transaction involving Clayton, Dubilier & Rice, strengthening expectations for additional healthcare packaging investment and portfolio expansion.
• January 2026 – Several healthcare packaging suppliers increased production of recyclable mono-material foam transport systems to address tightening sustainability standards in Europe and Japan.
• November 2025 – Pharmaceutical cold-chain infrastructure expansion across Asia increased procurement of insulated medical transport packaging using advanced polyethylene foam materials.
• July 2025 – JSP Corporation expanded specialty foam conversion capabilities in Europe to improve supply responsiveness for healthcare and industrial packaging applications.
• 2025–2026 – Multiple medical device manufacturers in China and Southeast Asia increased outsourcing of customized protective foam fabrication as exports of diagnostic systems and portable medical electronics continued rising.
• March 2026 – Demand for anti-static medical cushioning materials increased alongside growth in semiconductor-integrated diagnostic devices and advanced imaging equipment shipments.